Last reviewed · How we verify
morphine sulfate sustained-release capsules
At a glance
| Generic name | morphine sulfate sustained-release capsules |
|---|---|
| Also known as | Treatment A, Test Product, Test product |
| Sponsor | Actavis Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults (PHASE4)
- Breathlessness Exertion and Morphine Sulphate (PHASE3)
- Morphine for Treatment of Dyspnea in Patients With COPD (PHASE4)
- A Comparison of the Addiction Liability of Hydrocodone and Sustained Release Morphine (PHASE4)
- Sustained-release Morphine Pharmacokinetics in Roux-en-Y Gastric Bypass Subjects (PHASE4)
- Opioids for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease (PHASE3)
- Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions (PHASE1)
- Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on Applesauce (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |